BRIEF-Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes

Reuters11-20

BRIEF-<a href="https://laohu8.com/S/JYB">Jyong Biotech</a> Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes

Jyong Biotech Ltd MENS.O:

JYONG BIOTECH ANNOUNCES COMPLETION OF PRIMARY ENDPOINT STATISTICAL ANALYSIS FOR PHASE II CLINICAL TRIAL OF MCS-8 WITH POSITIVE OUTCOMES
JYONG BIOTECH LTD: MCS-8 REMAINS INVESTIGATIONAL NEW DRUG CANDIDATE & HAS NOT BEEN APPROVED FOR COMMERCIAL USE IN ANY JURISDICTION

Source text: ID:nGNX4nNYZZ

Further company coverage: MENS.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584327011?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 21:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584327011","market":"nz","top_or_hot":-1,"title":"BRIEF-Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/JYB\">Jyong Biotech</a> Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes</title></head><body><p>Jyong Biotech Ltd <span>MENS.O</span>:</p><ul><li><p>JYONG BIOTECH ANNOUNCES COMPLETION OF PRIMARY ENDPOINT STATISTICAL ANALYSIS FOR PHASE II CLINICAL TRIAL OF MCS-8 WITH POSITIVE OUTCOMES</p></li><li><p>JYONG BIOTECH LTD: MCS-8 REMAINS INVESTIGATIONAL NEW DRUG CANDIDATE &amp; HAS NOT BEEN APPROVED FOR COMMERCIAL USE IN ANY JURISDICTION</p></li></ul><p>Source text: <span>ID:nGNX4nNYZZ</span></p><p>Further company coverage: <span>MENS.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-20 21:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/JYB\">Jyong Biotech</a> Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes</title></head><body><p>Jyong Biotech Ltd <span>MENS.O</span>:</p><ul><li><p>JYONG BIOTECH ANNOUNCES COMPLETION OF PRIMARY ENDPOINT STATISTICAL ANALYSIS FOR PHASE II CLINICAL TRIAL OF MCS-8 WITH POSITIVE OUTCOMES</p></li><li><p>JYONG BIOTECH LTD: MCS-8 REMAINS INVESTIGATIONAL NEW DRUG CANDIDATE &amp; HAS NOT BEEN APPROVED FOR COMMERCIAL USE IN ANY JURISDICTION</p></li></ul><p>Source text: <span>ID:nGNX4nNYZZ</span></p><p>Further company coverage: <span>MENS.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0YV:1","article_id":"2584327011","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584327011","pubTimestamp":1763647045,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive OutcomesJyong Biotech Ltd MENS.O:JYONG BIOTECH ANNOUNCES COMPLETION","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","MENS":"健永生技"},"translate_title":"BRIEF-Jyong Biotech宣布完成MCS-8 II期临床试验的主要终点统计分析并取得积极结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MENS":0.9},"content_text":"BRIEF-Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive OutcomesJyong Biotech Ltd MENS.O:JYONG BIOTECH ANNOUNCES COMPLETION OF PRIMARY ENDPOINT STATISTICAL ANALYSIS FOR PHASE II CLINICAL TRIAL OF MCS-8 WITH POSITIVE OUTCOMESJYONG BIOTECH LTD: MCS-8 REMAINS INVESTIGATIONAL NEW DRUG CANDIDATE & HAS NOT BEEN APPROVED FOR COMMERCIAL USE IN ANY JURISDICTIONSource text: ID:nGNX4nNYZZFurther company coverage: MENS.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584327011","isCrawlerRequest":true}